PCR技术的全球市场：市场规模和占有率分析（依产品、技术、应用和最终用户）、工业需求预测（截至2030年）

全球PCR技术市场预计将以8.4%的复合年增长率成长，到2023年达到137.093亿美元，到2030年达到236.725亿美元。

这一增长是由遗传性疾病和传染病发病率的增加以及用于改进诊断技术的资金增加所推动的。此外，疾病早期诊断意识的提高和产品开发将进一步支持该行业的扩张。

北美市场领先

到 2023 年，北美地区将占据该行业的 40% 占有率，预计在整个十年内仍将保持最大地位。这是由于传染病的日益普及、大公司引进改进的 PCR 机器和耗材以及医疗基础设施的发展。

依细分市场的见解

2023年，试剂耗材品类将占据产业最大占有率，达到70%的占有率，这也是近10年来最大的。这是因为 PCR 检测经常不仅使用试剂，还使用耗材。

实时 PCR 类别预计将在 2023 年引领行业，并在未来几年以 8% 的惊人速度进一步发展。它是一种在全球广泛采用的方法，适用于多种应用，包括基因表现分析、诊断测试开发和癌症表型分析。

诊断类别所占占有率最大。这是因为 PCR 检测是诊断某些基因变化和传染病的一种非常精确的方法。

本报告分析了全球PCR技术市场，包括市场的基本结构、最新情况、主要推动和抑制因素以及全球、依地区和主要国家的市场规模前景（价值基础，2017-2030年） ），依产品、技术、应用和最终用户划分的详细趋势、市场竞争的现状以及主要公司的概况。

目录

第一章 调查范围

第二章 研究方法

第3章执行摘要

第四章 市场指标

第五章 产业展望

• 市场动态
  • 趋势
  • 促进因素
  • 抑制因素/课题
  • 促进/抑制因素影响分析
• 新型冠状病毒感染（COVID-19）的影响
• 波特五力分析

第六章 世界市场

• 概述
• 市场收入：依产品分类（2017-2030）
• 市场收入：依技术分类（2017-2030）
• 市场收入：依应用分类（2017-2030）
• 市场收入：依最终用户分类（2017-2030）
• 市场收入：依地区（2017-2030）

第七章 北美市场

• 概述
• 市场收入：依产品分类（2017-2030）
• 市场收入：依技术分类（2017-2030）
• 市场收入：依应用分类（2017-2030）
• 市场收入：依最终用户分类（2017-2030）
• 市场收入：依国家分类（2017-2030）

第八章欧洲市场

第九章亚太市场

第十章 拉丁美洲市场

第十一章 中东和非洲（MEA）市场

第十二章 美国市场

• 概述
• 市场收入：依产品分类（2017-2030）
• 市场收入：依技术分类（2017-2030）
• 市场收入：依应用分类（2017-2030）
• 市场收入：依最终用户分类（2017-2030）

第十三章 加拿大市场

第十四章 德国市场

第十五章 法国市场

第十六章 英国市场

第十七章 义大利市场

第十八章 西班牙市场

第十九章 日本市场

第20章 中国市场

第21章 印度市场

第22章澳洲市场

第23章 韩国市场

第24章 巴西市场

第25章 墨西哥市场

第26章 沙乌地阿拉伯市场

第27章南非市场

第28章 阿拉伯联合大公国（UAE）市场

第29章竞争格局

• 市场参与者及其提供的产品/服务的列表
• 主要企业竞争基准
• 主要公司的产品基准
• 近期策略发展状况

第三十章 公司简介

• F. Hoffmann-La Roche AG
• Thermo Fisher Scientific Inc.
• Bio-Rad Laboratories Inc.
• QIAGEN N.V.
• Takara Bio USA Inc.
• Agilent Technologies Inc.
• Standard BioTools Inc.
• Danaher Corporation
• Abbott Laboratories
• Merck Life Science Private Limited
• Becton, Dickinson and Company
• Eppendorf AG

第31章附录

The PCR technologies market generated USD 13,709.3 million in 2023, which will increase to USD 23,672.5 million, powering at an 8.4% CAGR, by 2030.

The growth is because of the increasing genetic disorders and infectious disease occurrence and rising funding to improve diagnostic technologies. Furthermore, the rising consciousness about early disease diagnosis and development in products will further assist this industry expansion.

The surging need for digital PCR kits and assays, consumables, and reagents, is a major driver for this industry, particularly since the pandemic. As the pandemic broke out, the need for digital PCR tests from life sciences and biotechnology firms substantially increased.

PCR tests were performed in various kinds of settings, from hospitals and airports to shopping malls and stadia, to detect and quarantine patients with the virus.

Additionally, COVID-19 is an important factor for the acceptance of the PCR technology as it was made a mandatory test for flyers across various nations.

The Indian government, in December 2022, made RT-PCR testing for COVID-19 compulsory for passengers coming from China, Japan, Hong Kong, Thailand, Singapore, and South Korea from January 2023 onward.

Moreover, France, in January 2023, prolonged its mandate for COVID-19 tests for people arriving from China. Further, France has urged the other 26 EU member states to test Chinese travelers for the virus.

The U.S. has also placed compulsory COVID-19 tests for individuals arriving from China. Additionally, the U.S. Centers for Disease Control and Prevention said that the nation's citizens should hold plans to travel to Hong Kong, Macau, and China until further notice.

North America is Leading Market

North America led the industry in 2023, with a 40% share, and it will remain the largest throughout this decade. This can be because of the increasing prevalence of infectious diseases, the introduction of improved PCR instruments and consumables by the key players, and the development of the healthcare infrastructure.

Moreover, the growing partnerships between businesses are also aiding the industry expansion.

For example, Takara Bio USA Inc., in October 2022, collaborated with BioExcel Diagnostics Laboratory to develop a new technique for detecting infectious illnesses that result in syndromes and authenticate its efficiency.

Segmentation Insights

In 2023, the reagents and consumables category was the largest contributor to the industry, with a 70% share, and it will remain the largest during this decade. This can be ascribed to the regular use of consumables as well as reagents for PCR testing.

The real-time PCR category led the industry in 2023, and will further advance at a significant rate, of 8%, in the coming years. It is an extensively employed method globally for different applications, including gene expression analysis, diagnostic test development, and cancer phenotyping.

The diagnostics category accounted for the largest share. This is because PCR tests are a very precise means to diagnose specific genetic changes and infectious ailments.

Competition Analysis

Major players in this industry are entering into mergers and acquisitions to reach more people, increase their revenue, and improve the technology of their products.

Bio-Rad Laboratories Inc., in August 2022, signed a deal to acquire all the outstanding shares of Curiosity Diagnostics Sp. Z. o. o.'s for USD 170 million.

The contract provided Bio-Rad access to Curiosity Diagnostics' under-development sample-to-answer, rapid polymerase chain reaction system for molecular diagnostics.

With the rising funding to improve diagnostic technologies, the PCR technologies industry will grow significantly in the coming years.

Table of Contents

Chapter 1. Research Scope

• 1.1. Research Objectives
• 1.2. Market Definition
• 1.3. Analysis Period
• 1.4. Market Size Breakdown by Segments
  • 1.4.1. Market size breakdown, by product
  • 1.4.2. Market size breakdown, by technique
  • 1.4.3. Market size breakdown, by application
  • 1.4.4. Market size breakdown, by end user
  • 1.4.5. Market size breakdown, by region
  • 1.4.6. Market size breakdown, by country
• 1.5. Market Data Reporting Unit
  • 1.5.1. Value
• 1.6. Key Stakeholders

Chapter 2. Research Methodology

• 2.1. Secondary Research
  • 2.1.1. Paid
  • 2.1.2. Unpaid
  • 2.1.3. P&S Intelligence database
• 2.2. Primary Research
• 2.3. Market Size Estimation
• 2.4. Data Triangulation
• 2.5. Currency Conversion Rates
• 2.6. Assumptions for the Study
• 2.7. Notes and Caveats

Chapter 3. Executive Summary

Chapter 4. Market Indicators

Chapter 5. Industry Outlook

• 5.1. Market Dynamics
  • 5.1.1. Trends
  • 5.1.2. Drivers
  • 5.1.3. Restraints/challenges
  • 5.1.4. Impact analysis of drivers/restraints
• 5.2. Impact of COVID-19
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Bargaining power of buyers
  • 5.3.2. Bargaining power of suppliers
  • 5.3.3. Threat of new entrants
  • 5.3.4. Intensity of rivalry
  • 5.3.5. Threat of substitutes

Chapter 6. Global Market

• 6.1. Overview
• 6.2. Market Revenue, by Product (2017-2030)
• 6.3. Market Revenue, by Technique (2017-2030)
• 6.4. Market Revenue, by Application (2017-2030)
• 6.5. Market Revenue, by End User (2017-2030)
• 6.6. Market Revenue, by Region (2017-2030)

Chapter 7. North America Market

• 7.1. Overview
• 7.2. Market Revenue, by Product (2017-2030)
• 7.3. Market Revenue, by Technique (2017-2030)
• 7.4. Market Revenue, by Application (2017-2030)
• 7.5. Market Revenue, by End User (2017-2030)
• 7.6. Market Revenue, by Country (2017-2030)

Chapter 8. Europe Market

• 8.1. Overview
• 8.2. Market Revenue, by Product (2017-2030)
• 8.3. Market Revenue, by Technique (2017-2030)
• 8.4. Market Revenue, by Application (2017-2030)
• 8.5. Market Revenue, by End User (2017-2030)
• 8.6. Market Revenue, by Country (2017-2030)

Chapter 9. APAC Market

• 9.1. Overview
• 9.2. Market Revenue, by Product (2017-2030)
• 9.3. Market Revenue, by Technique (2017-2030)
• 9.4. Market Revenue, by Application (2017-2030)
• 9.5. Market Revenue, by End User (2017-2030)
• 9.6. Market Revenue, by Country (2017-2030)

Chapter 10. LATAM Market

• 10.1. Overview
• 10.2. Market Revenue, by Product (2017-2030)
• 10.3. Market Revenue, by Technique (2017-2030)
• 10.4. Market Revenue, by Application (2017-2030)
• 10.5. Market Revenue, by End User (2017-2030)
• 10.6. Market Revenue, by Country (2017-2030)

Chapter 11. MEA Market

• 11.1. Overview
• 11.2. Market Revenue, by Product (2017-2030)
• 11.3. Market Revenue, by Technique (2017-2030)
• 11.4. Market Revenue, by Application (2017-2030)
• 11.5. Market Revenue, by End User (2017-2030)
• 11.6. Market Revenue, by Country (2017-2030)

Chapter 12. U.S. Market

• 12.1. Overview
• 12.2. Market Revenue, by Product (2017-2030)
• 12.3. Market Revenue, by Technique (2017-2030)
• 12.4. Market Revenue, by Application (2017-2030)
• 12.5. Market Revenue, by End User (2017-2030)

Chapter 13. Canada Market

• 13.1. Overview
• 13.2. Market Revenue, by Product (2017-2030)
• 13.3. Market Revenue, by Technique (2017-2030)
• 13.4. Market Revenue, by Application (2017-2030)
• 13.5. Market Revenue, by End User (2017-2030)

Chapter 14. Germany Market

• 14.1. Overview
• 14.2. Market Revenue, by Product (2017-2030)
• 14.3. Market Revenue, by Technique (2017-2030)
• 14.4. Market Revenue, by Application (2017-2030)
• 14.5. Market Revenue, by End User (2017-2030)

Chapter 15. France Market

• 15.1. Overview
• 15.2. Market Revenue, by Product (2017-2030)
• 15.3. Market Revenue, by Technique (2017-2030)
• 15.4. Market Revenue, by Application (2017-2030)
• 15.5. Market Revenue, by End User (2017-2030)

Chapter 16. U.K. Market

• 16.1. Overview
• 16.2. Market Revenue, by Product (2017-2030)
• 16.3. Market Revenue, by Technique (2017-2030)
• 16.4. Market Revenue, by Application (2017-2030)
• 16.5. Market Revenue, by End User (2017-2030)

Chapter 17. Italy Market

• 17.1. Overview
• 17.2. Market Revenue, by Product (2017-2030)
• 17.3. Market Revenue, by Technique (2017-2030)
• 17.4. Market Revenue, by Application (2017-2030)
• 17.5. Market Revenue, by End User (2017-2030)

Chapter 18. Spain Market

• 18.1. Overview
• 18.2. Market Revenue, by Product (2017-2030)
• 18.3. Market Revenue, by Technique (2017-2030)
• 18.4. Market Revenue, by Application (2017-2030)
• 18.5. Market Revenue, by End User (2017-2030)

Chapter 19. Japan Market

• 19.1. Overview
• 19.2. Market Revenue, by Product (2017-2030)
• 19.3. Market Revenue, by Technique (2017-2030)
• 19.4. Market Revenue, by Application (2017-2030)
• 19.5. Market Revenue, by End User (2017-2030)

Chapter 20. China Market

• 20.1. Overview
• 20.2. Market Revenue, by Product (2017-2030)
• 20.3. Market Revenue, by Technique (2017-2030)
• 20.4. Market Revenue, by Application (2017-2030)
• 20.5. Market Revenue, by End User (2017-2030)

Chapter 21. India Market

• 21.1. Overview
• 21.2. Market Revenue, by Product (2017-2030)
• 21.3. Market Revenue, by Technique (2017-2030)
• 21.4. Market Revenue, by Application (2017-2030)
• 21.5. Market Revenue, by End User (2017-2030)

Chapter 22. Australia Market

• 22.1. Overview
• 22.2. Market Revenue, by Product (2017-2030)
• 22.3. Market Revenue, by Technique (2017-2030)
• 22.4. Market Revenue, by Application (2017-2030)
• 22.5. Market Revenue, by End User (2017-2030)

Chapter 23. South Korea Market

• 23.1. Overview
• 23.2. Market Revenue, by Product (2017-2030)
• 23.3. Market Revenue, by Technique (2017-2030)
• 23.4. Market Revenue, by Application (2017-2030)
• 23.5. Market Revenue, by End User (2017-2030)

Chapter 24. Brazil Market

• 24.1. Overview
• 24.2. Market Revenue, by Product (2017-2030)
• 24.3. Market Revenue, by Technique (2017-2030)
• 24.4. Market Revenue, by Application (2017-2030)
• 24.5. Market Revenue, by End User (2017-2030)

Chapter 25. Mexico Market

• 25.1. Overview
• 25.2. Market Revenue, by Product (2017-2030)
• 25.3. Market Revenue, by Technique (2017-2030)
• 25.4. Market Revenue, by Application (2017-2030)
• 25.5. Market Revenue, by End User (2017-2030)

Chapter 26. Saudi Arabia Market

• 26.1. Overview
• 26.2. Market Revenue, by Product (2017-2030)
• 26.3. Market Revenue, by Technique (2017-2030)
• 26.4. Market Revenue, by Application (2017-2030)
• 26.5. Market Revenue, by End User (2017-2030)

Chapter 27. South Africa Market

• 27.1. Overview
• 27.2. Market Revenue, by Product (2017-2030)
• 27.3. Market Revenue, by Technique (2017-2030)
• 27.4. Market Revenue, by Application (2017-2030)
• 27.5. Market Revenue, by End User (2017-2030)

Chapter 28. U.A.E. Market

• 28.1. Overview
• 28.2. Market Revenue, by Product (2017-2030)
• 28.3. Market Revenue, by Technique (2017-2030)
• 28.4. Market Revenue, by Application (2017-2030)
• 28.5. Market Revenue, by End User (2017-2030)

Chapter 29. Competitive Landscape

• 29.1. List of Market Players and their Offerings
• 29.2. Competitive Benchmarking of Key Players
• 29.3. Product Benchmarking of Key Players
• 29.4. Recent Strategic Developments

Chapter 30. Company Profiles

• 30.1. F. Hoffmann-La Roche AG
  • 30.1.1. Business overview
  • 30.1.2. Product and service offerings
  • 30.1.3. Key financial summary
• 30.2. Thermo Fisher Scientific Inc.
  • 30.2.1. Business overview
  • 30.2.2. Product and service offerings
  • 30.2.3. Key financial summary
• 30.3. Bio-Rad Laboratories Inc.
  • 30.3.1. Business overview
  • 30.3.2. Product and service offerings
  • 30.3.3. Key financial summary
• 30.4. QIAGEN N.V.
  • 30.4.1. Business overview
  • 30.4.2. Product and service offerings
  • 30.4.3. Key financial summary
• 30.5. Takara Bio USA Inc.
  • 30.5.1. Business overview
  • 30.5.2. Product and service offerings
  • 30.5.3. Key financial summary
• 30.6. Agilent Technologies Inc.
  • 30.6.1. Business overview
  • 30.6.2. Product and service offerings
  • 30.6.3. Key financial summary
• 30.7. Standard BioTools Inc.
  • 30.7.1. Business overview
  • 30.7.2. Product and service offerings
  • 30.7.3. Key financial summary
• 30.8. Danaher Corporation
  • 30.8.1. Business overview
  • 30.8.2. Product and service offerings
  • 30.8.3. Key financial summary
• 30.9. Abbott Laboratories
  • 30.9.1. Business overview
  • 30.9.2. Product and service offerings
  • 30.9.3. Key financial summary
• 30.10. Merck Life Science Private Limited
  • 30.10.1. Business overview
  • 30.10.2. Product and service offerings
  • 30.10.3. Key financial summary
• 30.11. Becton, Dickinson and Company
  • 30.11.1. Business overview
  • 30.11.2. Product and service offerings
  • 30.11.3. Key financial summary
• 30.12. Eppendorf AG
  • 30.12.1. Business overview
  • 30.12.2. Product and service offerings
  • 30.12.3. Key financial summary

Chapter 31. Appendix

• 31.1. Abbreviations
• 31.2. Sources and References
• 31.3. Related Reports